8-K 1 w85002e8vk.htm FORM 8-K e8vk
 



SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 31, 2003

GUILFORD PHARMACEUTICALS INC.
(Exact name of registrant as specified in its charter)

         
Delaware   0-23736   52-1841960

 
 
(State or other jurisdiction of   (Commission File Number)   (I.R.S. Employer
incorporation or organization)       Identification No.)
     
6611 Tributary Street    
Baltimore, Maryland   21224
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (410) 631-6300




(Former name or former address, if changed since last report)




Exhibit Index is on page 4.

 


 

INFORMATION TO BE INCLUDED IN THE REPORT

     
Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits.
 
    (c) Exhibits
     
99.1   Written Statement of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350)
     
Item 9.   Regulation FD Disclosure

                          In connection with the Annual Report of Guilford Pharmaceuticals Inc. (the “Company”) on Form 10-K for the year ended December 31, 2002 as filed with the Securities and Exchange Commission on the date hereof, the Company filed with the Securities and Exchange Commission as correspondence the certificate required under 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002.

                         A copy of this certificate is attached hereto as Exhibit 99.1.

 


 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
    GUILFORD PHARMACEUTICALS INC.
 
Dated: March 31, 2003   By: /s/ Andrew R. Jordan
Andrew R. Jordan
Sr. Vice President, Chief Financial
Officer, and Treasurer (Principal
Financial Officer and Principal
Accounting Officer)

 


 

INDEX TO EXHIBITS

             
Exhibit            

           
Number   Exhibit Description   Page

 
 
99.1   Written Statement of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)     5